Reuters logo
BRIEF-Atossa Genetics announces preliminary results from Phase 1 study of topical Endoxifen
September 14, 2017 / 5:29 PM / 2 months ago

BRIEF-Atossa Genetics announces preliminary results from Phase 1 study of topical Endoxifen

Sept 14 (Reuters) - Atossa Genetics Inc:

* Atossa Genetics announces preliminary results from Phase 1 study of topical Endoxifen

* Atossa Genetics Inc says expects to announce results from oral arm of Phase 1 study in next 30-60 days

* Atossa Genetics Inc says ‍all objectives were successfully met in trial​

* Atossa Genetics says‍ no clinically significant safety signals,no clinically significant adverse events in participants receiving topical Endoxifen​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below